Oftan Dexa (Dexamethasone)

Dexamethasone, the active ingredient in Oftan Dexa, is a corticosteroid presented as a strength/form for systemic use. It reduces inflammation and modulates immune responses in a variety of clinical settings, including allergic reactions, autoimmune disorders, and certain cancers. GNH USA supplies Oftan Dexa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

GNH USA supplies Oftan Dexa as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Oftan Dexa is a corticosteroid that acts on inflammatory and immune pathways across several disease families.

- Allergic reactions: helps control severe hypersensitivity and anaphylaxis symptoms. - Autoimmune disorders: reduces inflammation in conditions such as rheumatoid arthritis and systemic lupus erythematosus. - Oncology supportive care: mitigates chemotherapy‑induced nausea, vomiting and cerebral edema. - Dermatologic inflammation: treats severe eczema and psoriasis flares. - Respiratory inflammation: improves outcomes in acute asthma exacerbations. - Cerebral edema: decreases intracranial pressure associated with brain tumors or trauma.

Adverse reactions to dexamethasone vary with dose, duration and route of administration.

Common Side Effects: - Elevated blood glucose: may worsen diabetes control. - Mood changes: irritability, anxiety or insomnia. - Gastrointestinal discomfort: nausea, dyspepsia or ulcer risk. - Fluid retention: facial rounding and peripheral edema. - Skin thinning: easy bruising or delayed wound healing.

Serious or Rare Side Effects: - Severe infection: heightened susceptibility to bacterial, viral or fungal pathogens. - Adrenal suppression: risk of adrenal insufficiency on abrupt discontinuation. - Osteoporosis: increased fracture risk with long‑term use. - Psychiatric effects: psychosis or severe mood disorders. - Vision changes: cataract formation or intra‑ocular pressure rise.

When using dexamethasone, careful assessment and monitoring are essential to minimise risks.

- Assess infection risk: evaluate for active or latent infections before initiating therapy. - Monitor glucose: check blood sugar regularly in diabetic or pre‑diabetic patients. - Evaluate bone health: consider calcium and vitamin D supplementation for long‑term use. - Review psychiatric history: watch for mood swings or psychotic symptoms. - Avoid abrupt cessation: taper the dose gradually under medical supervision. - Store at ambient temperature: keep below 25°C, protect from moisture and light in the original packaging.

Dexamethasone can alter the pharmacokinetics or pharmacodynamics of several co‑administered medicines.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase dexamethasone exposure and toxicity. - Live vaccines: immunosuppression can reduce vaccine efficacy and increase infection risk.

Moderate Interactions (Monitor Closely): - Antidiabetic agents: dexamethasone may raise blood glucose, requiring dose adjustments. - Anticoagulants (e.g., warfarin): glucocorticoids can enhance anticoagulant effect, increasing bleeding risk. - NSAIDs: combined use raises gastrointestinal ulcer risk. - Diuretics: may potentiate hypokalemia. - Antihypertensives: glucocorticoids can blunt antihypertensive response.